In general, wild-type MV infects cells via CD150/SLAM on lymphocytes and nectin-4 on epithelial cells, while MV vaccine strains primarily use CD46 as receptors [29], which is commonly over-expressed on the surface of tumor cells. This evidence concerns the gene SLAMF1 and neoplasm.